101 related articles for article (PubMed ID: 26668125)
1. Serum protein profiles of patients with lung cancer of different histological types.
Yang RH; Tian RF; Ren QL; Chui HY; Guo ST; Zhang XD; Song X
Asia Pac J Clin Oncol; 2016 Mar; 12(1):70-6. PubMed ID: 26668125
[TBL] [Abstract][Full Text] [Related]
2. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
3. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
4. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
6. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
7. Discovery and identification of Serum Amyloid A protein elevated in lung cancer serum.
Dai S; Wang X; Liu L; Liu J; Wu S; Huang L; Xiao X; He D
Sci China C Life Sci; 2007 Jun; 50(3):305-11. PubMed ID: 17609886
[TBL] [Abstract][Full Text] [Related]
8. Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.
Zhang Y; Chen X; Hu Y; Du S; Shen L; He Y; Zhang Y; Zhang X; Li H; Yung RC
Respir Res; 2013 Feb; 14(1):18. PubMed ID: 23399022
[TBL] [Abstract][Full Text] [Related]
9. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
[TBL] [Abstract][Full Text] [Related]
10. [Proteinchip-flight mass spectrometry for screening differentially expressed proteins in the serum of cervical cancer patients].
Cai SN; Liu GB; Guo XH; Chen JG; Zhang J; Wu YL; Liang WJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):32-5. PubMed ID: 19218106
[TBL] [Abstract][Full Text] [Related]
11. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
12. Importance of serum SELDI-TOF-MS analysis in the diagnosis of early lung cancer.
Simsek C; Sonmez O; Keyf AI; Yurdakul AS; Ozturk C; Gulbahar O; Ozmen F; Zengin N; Kubilay D; Karatayli SC; Bozdayi M
Asian Pac J Cancer Prev; 2013; 14(3):2037-42. PubMed ID: 23679315
[TBL] [Abstract][Full Text] [Related]
13. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
Periyasamy A; Gopisetty G; Veluswami S; Joyimallaya Subramanium M; Thangarajan R
Biomarkers; 2015; 20(5):292-8. PubMed ID: 26329525
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of serum from stage I lung squamous cell carcinoma patients.
Li XJ; Wu QF; He DL; Fu JK; Jin X
Asian Pac J Cancer Prev; 2013; 14(4):2273-6. PubMed ID: 23725126
[TBL] [Abstract][Full Text] [Related]
16. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
17. [The study of differential proteins in patients with peripheral lung cancer by surface-enhanced laser desorption/ionization time of flight mass technology].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jan; 34(1):30-3. PubMed ID: 21429416
[TBL] [Abstract][Full Text] [Related]
18. Reduced transthyretin expression in sera of lung cancer.
Liu L; Liu J; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
Cancer Sci; 2007 Oct; 98(10):1617-24. PubMed ID: 17683510
[TBL] [Abstract][Full Text] [Related]
19. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.
Hu Q; Huang Y; Wang Z; Tao H; Liu J; Yan L; Wang K
Hepatogastroenterology; 2012 Sep; 59(118):1902-6. PubMed ID: 22193438
[TBL] [Abstract][Full Text] [Related]
20. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
